Winfield Associates’s Pfizer PFE Stock Holding History

Winfield Associates’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	$1.1M	Sell	21,247 -310	-1%	-$16K	0.4%	61
2021 Q4	$1.27M	Buy	21,557 +200	+0.9%	+$11.8K	0.42%	59
2021 Q3	$919K	Buy	21,357 +375	+2%	+$16.1K	0.34%	67
2021 Q2	$822K	Buy	20,982 +1,235	+6%	+$48.4K	0.3%	74
2021 Q1	$715K	Buy	19,747 +1,205	+6%	+$43.6K	0.29%	73
2020 Q4	$683K	Sell	18,542 -3,093	-14%	-$114K	0.29%	75
2020 Q3	$753K	Buy	21,635 +5,575	+35%	+$194K	0.36%	62
2020 Q2	$498K	Buy	+16,060	New	+$498K	0.26%	76
2020 Q1	–	Sell	-9,140	Closed	-$340K	–	139
2019 Q4	$340K	Sell	9,140 -3,268	-26%	-$122K	0.16%	98
2019 Q3	$423K	Sell	12,408 -6,640	-35%	-$226K	0.21%	85
2019 Q2	$783K	Hold	19,048	–	–	0.41%	58
2019 Q1	$768K	Hold	19,048	–	–	0.41%	56
2018 Q4	$789K	Buy	19,048 +2,635	+16%	+$109K	0.48%	50
2018 Q3	$686K	Hold	16,413	–	–	0.34%	61
2018 Q2	$565K	Buy	16,413 +422	+3%	+$14.5K	0.3%	68
2018 Q1	$538K	Sell	15,991 -2,577	-14%	-$86.7K	0.29%	77
2017 Q4	$640K	Buy	18,568 +457	+3%	+$15.8K	0.32%	73
2017 Q3	$613K	Sell	18,111 -1,316	-7%	-$44.5K	0.32%	71
2017 Q2	$620K	Buy	19,427 +241	+1%	+$7.69K	0.34%	68
2017 Q1	$623K	Sell	19,186 -597	-3%	-$19.4K	0.35%	69
2016 Q4	$609K	Sell	19,783 -577	-3%	-$17.8K	0.37%	72
2016 Q3	$655K	Buy	20,360 +3,162	+18%	+$102K	0.41%	68
2016 Q2	$575K	Sell	17,198 -34	-0.2%	-$1.14K	0.37%	69
2016 Q1	$485K	Buy	17,232 +1,339	+8%	+$37.7K	0.33%	71
2015 Q4	$487K	Buy	15,893 +632	+4%	+$19.4K	0.33%	69
2015 Q3	$455K	Sell	15,261 -3,349	-18%	-$99.8K	0.34%	66
2015 Q2	$592K	Sell	18,610 -527	-3%	-$16.8K	0.41%	64
2015 Q1	$632K	Sell	19,137 -252	-1%	-$8.32K	0.44%	63
2014 Q4	$573K	Sell	19,389 -8,353	-30%	-$247K	0.42%	68
2014 Q3	$778K	Sell	27,742 -340	-1%	-$9.54K	0.58%	54
2014 Q2	$790K	Sell	28,082 -3,460	-11%	-$97.3K	0.57%	53
2014 Q1	$961K	Sell	31,542 -671	-2%	-$20.4K	0.79%	41
2013 Q4	$936K	Buy	+32,213	New	+$936K	0.77%	41